Cannabis Science Inc (OTCMKTS:CBIS) Moves Up Seeding Schedule to 350 Acres, Shares Could Continue to Rise

1032

Cannabis Science Inc (OTCMKTS:CBIS) shares could continue to rise, following its recent acquisition. Now, Cannabis Science recently negotiated a deal to begin seeding in Minden County, which adds to the farm land it had in the San Joaquin Valley, California. We’ll get to that news later, but first, you’ll need some company background.

 

Cannabis Science Inc aims to take advantage of its unique understanding of metabolic processes in order to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabis Science works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. The company’s initial focus is on skin cancers, HIV/AIDS, and neurological conditions. That in mind, Cannabis Science is moving forward with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

 

Moving on, let’s get into the recent developments in Cannabis Science Inc (OTCMKTS:CBIS) The company negotiated a deal to begin seeding the 100 Acres in Nevada, which adds to the 250 acres of farm lands in California, for the company’s Industrial Commercial Hemp Grow Initiatives.

 

According to Cannabis Science Inc. President, CEO & Co-Founder Mr. Raymond C. Dabney, “We are heading to Harvard Medical School shortly to present our cannabinoid findings and action plans to success at the Global Health Summit, these types of large land deals are at the heart of our growth and will certainly be a part of my presentation for the world to understand. This is certainly the strongest way to bring more of our formulations to market immediately and with due course FDA resolve.”

 

Dabney added, “We have been releasing test products through the State by State initiatives in California though our partners and licensees, our next project for the Industrial Commercial Hemp Grow Initiatives, and of course our FDA drug development programs. This type of aggressive progress certainly gives us the insight required to continue down our path of accomplishments. There comes a point when you must sit back and look at what is going on with the industry and where you belong.”

 

Now, this drives up the seeding schedule in the near future to 350 Acres. That in mind, the company could grow substantially more for its Industrial Commercial Hemp Grow Initiatives, which could potentially drive its revenues and earnings.

 

Cannabis Science CEO continued, “Cannabis Science, RCDU, and its Sovereign partners look to be one of the country’s largest Industrial Commercial Hemp producers as this seeding schedule now encompasses 350 acres, all of which is scheduled to be planted at once on Sovereign lands in San Joaquin MBS and Douglas County. Each acre has the potential yield of up to 1,600 pounds per acre with wholesale prices ranging from 500 USD per pound. Potentially Cannabis Science, RCDU, Investors, and its Sovereign partners are looking at annual harvests yields grossing revenue several hundred million dollars.”

 

Now that in mind, with this increase in acreage, Cannabis Science could potentially bring in revenues of over $200M. That in mind, if the company is able to execute properly, and all goes well, its shares could potentially continue its recent meteoric rise. The company still has some potential catalysts, as it has been releasing some test products. That said, you might not want to miss any developments in CBIS. To stay up to date, all you have to do is provide us with your email address in the box below, and you’ll be subscribed to our free newsletter. Thereafter, we could send you updates, if any, on CBIS.

Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in CBIS stock, short or long.

LEAVE A REPLY